(Q33884600)

29 July 2017

1 reference

title

Atopic dermatitis: from the genes to skin lesions (English)

1 reference

29 July 2017

1 reference

Wollenberg A

1

1 reference

29 July 2017

Bieber T

series ordinal

2

1 reference

29 July 2017

publication date

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

55

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

205-213

1 reference

Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Practical management of atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Atopic dermatitis: recent trends in pathogenesis and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Pathogenesis of atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Pathogenesis of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Fc epsilon RI-expressing antigen-presenting cells: new players in the atopic game

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Tacrolimus: the drug for the turn of the millennium?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Development and validation of diagnostic scores for atopic dermatitis incorporating criteria of data quality and practical usefulness

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Changes in the reported prevalence of childhood eczema since the 1939-45 war

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Parental smoking, breast feeding, and respiratory infection in development of allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

The epidemiology and genetics of atopic allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

No evidence for an association between a variant of the mast cell chymase gene and atopic dermatitis based on case-control and haplotype-relative-risk analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Linkage and allelic association of atopy and markers flanking the IL4-receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

The expanding universe of T-cell subsets: Th1, Th2 and more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

IgE-dependent antigen focusing by human B lymphocytes is mediated by the low-affinity receptor for IgE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Induction of Fc epsilon R2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and gamma interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Demonstration of the high-affinity IgE receptor on human Langerhans cells in normal and diseased skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Human keratinocytes release the endogenous beta-galactoside-binding soluble lectin immunoglobulin E (IgE-binding protein) which binds to Langerhans cells where it modulates their binding capacity for IgE glycoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Treatment of severe atopic dermatitis with extracorporeal photopheresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Chromosome 11 q13 and atopy underlying atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

Atopic dermatitis in children: who cares? Who pays?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

What exactly is "atopy"?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Atopic dermatitis: triggering factors.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Validation of the diagnostic criteria for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

The millennium criteria for the diagnosis of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Role of T cells and cytokines in the intrinsic form of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

The incidence of allergy--has it changed?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Breast-feeding of allergic infants

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

The rising trends in asthma and allergic disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Langerhans cell phenotyping: a new tool for differential diagnosis of inflammatory skin diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Linkage between atopy and the IgE high-affinity receptor gene at 11q13 in atopic dermatitis families

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Lack of linkage between atopy and locus 11q13

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Association between genetic variants of mast-cell chymase and eczema

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Association between mast cell chymase genotype and atopic eczema: comparison between patients with atopic eczema alone and those with atopic eczema and atopic respiratory disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

The interleukin-4 receptor gene (IL4R) maps to 16p11.2–16p12.1 in human and to the distal region of mouse chromosome 7

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Reduced levels of prostaglandin precursors in the blood of atopic patients: defective delta-6-desaturase function as a biochemical basis for atopy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Polyunsaturated fatty acids in school children in relation to allergy and serum IgE levels

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Mast cells are one major source of interleukin-4 in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

The high-affinity receptor for IgE is the predominant IgE-binding structure in lesional skin of atopic dermatitis patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Two populations of CD1a+ epidermal dendritic cells expressing B7 molecules in human skin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Evaluating the relevance of aeroallergen sensitization in atopic eczema with the atopy patch test: a randomized, double-blind multicenter study. Atopy Patch Test Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Neuropeptides and Langerhans cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

[Immunosuppressive macrolides and their use in dermatology]

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: in vivo pharmacology

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00115.X

7 January 2021

10.1034/J.1398-9995.2000.00115.X

Identifiers

DOI

1 reference

29 July 2017

1 reference